相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients
Dongjie Chen et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Molecular Characteristics, Clinical Significance, and Cancer Immune Interactions of Angiogenesis-Associated Genes in Gastric Cancer
Xin Qing et al.
FRONTIERS IN IMMUNOLOGY (2022)
Guanylate-Binding Protein 1 as a Potential Predictor of Immunotherapy: A Pan-Cancer Analysis
Yaqi Zhao et al.
FRONTIERS IN GENETICS (2022)
Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer
Martin Nunez Abad et al.
CANCERS (2022)
Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response
Zhen Zhang et al.
GENOME MEDICINE (2022)
Liver glycogen phosphorylase is upregulated in glioblastoma and provides a metabolic vulnerability to high dose radiation
Christos E. Zois et al.
CELL DEATH & DISEASE (2022)
GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels
Chun-Jie Liu et al.
BRIEFINGS IN BIOINFORMATICS (2022)
Immune suppression in gliomas
Matthew M. Grabowski et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Altered glycosylation in cancer: A promising target for biomarkers and therapeutics
Divya Thomas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Identification of diverse tumor endothelial cell populations in malignant glioma
Jeff C. Carlson et al.
NEURO-ONCOLOGY (2021)
Genotoxic therapy and resistance mechanism in gliomas
Fengchao Lang et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Diffuse Glioma Heterogeneity and Its Therapeutic Implications
James G. Nicholson et al.
CANCER DISCOVERY (2021)
D-Mannose Slows Glioma Growth by Modulating Myeloperoxidase Activity
Negin Jalali Motlagh et al.
CANCERS (2021)
Immunotherapy for Glioblastoma: Current Progress and Challenge
Miranda W. Yu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Renata Ferrarotto et al.
CLINICAL CANCER RESEARCH (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis
Yousra Mohamed Abd-El-Halim et al.
EBIOMEDICINE (2021)
Tumor-Infiltrating PD-1hiCD8+-T-Cell Signature as an Effective Biomarker for Immune Checkpoint Inhibitor Therapy Response Across Multiple Cancers
Zhenyu Yang et al.
FRONTIERS IN ONCOLOGY (2021)
Metabolic Remodeling in Glioma Immune Microenvironment: Intercellular Interactions Distinct From Peripheral Tumors
Runze Qiu et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Current Understanding of Central Nervous System Drainage Systems: Implications in the Context of Neurodegenerative Diseases
Vladimir N. Nikolenko et al.
CURRENT NEUROPHARMACOLOGY (2020)
Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectin
Sophie A. Dusoswa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
Florian Klemm et al.
CELL (2020)
Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development
Maria B. Garcia-Fabiani et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma
Junhui Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
Chunxiao Li et al.
MOLECULAR CANCER (2020)
High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment
Lissete Sanchez-Magraner et al.
CANCER RESEARCH (2020)
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
Willemijn S M E Theelen et al.
Lancet Respiratory Medicine (2020)
Glycosylation in health and disease
Colin Reily et al.
NATURE REVIEWS NEPHROLOGY (2019)
Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells
Xihong Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Application of PD-1 Blockade in Cancer Immunotherapy
Xiaomo Wu et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Stefan Mereiter et al.
CANCER CELL (2019)
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold
David W. Vredevoogd et al.
CELL (2019)
Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome
Xiaofan Lu et al.
NEOPLASIA (2019)
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang et al.
MOLECULAR CANCER (2019)
Glioma epigenetics: From subclassification to novel treatment options
Olga Gusyatiner et al.
SEMINARS IN CANCER BIOLOGY (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Selective Modulation of TnF-TnFRs Signaling: insights for Multiple Sclerosis Treatment
Valentina Pegoretti et al.
FRONTIERS IN IMMUNOLOGY (2018)
IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy
Lionel B. Ivashkiv
NATURE REVIEWS IMMUNOLOGY (2018)
The tumour glyco-code as a novel immune checkpoint for immunotherapy
Ernesto Rodriguez et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Tim-3 and its role in regulating anti-tumor immunity
Madhumita Das et al.
IMMUNOLOGICAL REVIEWS (2017)
Immune microenvironment of gliomas
Anna Gieryng et al.
LABORATORY INVESTIGATION (2017)
Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH
Jyotsna U. Rao et al.
SCIENTIFIC REPORTS (2017)
Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation
Lindsey Araujo et al.
ELIFE (2017)
Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities
Shanmugasundaram Ganapathy-Kanniappan
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now
Joaquin Bellmunt et al.
CANCER TREATMENT REVIEWS (2017)
Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma
Rajneet K. Oberoi et al.
NEURO-ONCOLOGY (2016)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
Molecular control of activation and priming in macrophages
Christopher K. Glass et al.
NATURE IMMUNOLOGY (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
Nivolumab plus ipilimumab in the treatment of advanced melanoma
Katy K. Tsai et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Glycosylation in cancer: mechanisms and clinical implications
Salome S. Pinho et al.
NATURE REVIEWS CANCER (2015)
Review: Molecular mechanism of microglia stimulated glioblastoma invasion
Salvatore J. Coniglio et al.
MATRIX BIOLOGY (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets
Yujin Hoshida et al.
PLOS ONE (2007)
Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation
Ken S. Lau et al.
CELL (2007)
Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences
RD Stout et al.
JOURNAL OF IMMUNOLOGY (2005)
The sweet and sour of cancer: Glycans as novel therapeutic targets
MM Fuster et al.
NATURE REVIEWS CANCER (2005)
Cytotoxic T lymphocytes: All roads lead to death
M Barry et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Clinical correlations of α2,6-sialyltransferase expression in colorectal cancer patients
M Lise et al.
HYBRIDOMA (2000)
M-1/M-2 macrophages and the Th1/Th2 paradigm
CD Mills et al.
JOURNAL OF IMMUNOLOGY (2000)